Masimo Co. (NASDAQ:MASI – Get Rating) – Jefferies Financial Group lowered their FY2022 earnings estimates for Masimo in a report issued on Wednesday, November 9th. Jefferies Financial Group analyst M. Taylor now forecasts that the medical equipment provider will post earnings of $4.48 per share for the year, down from their previous estimate of $4.52. Jefferies Financial Group currently has a “Buy” rating and a $180.00 target price on the stock. The consensus estimate for Masimo’s current full-year earnings is $4.47 per share. Jefferies Financial Group also issued estimates for Masimo’s Q4 2022 earnings at $1.21 EPS.
Masimo (NASDAQ:MASI – Get Rating) last released its earnings results on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, topping the consensus estimate of $1.19 by $0.16. Masimo had a net margin of 12.68% and a return on equity of 17.39%. The firm had revenue of $565.30 million for the quarter, compared to the consensus estimate of $540.56 million. During the same quarter in the previous year, the firm earned $0.94 earnings per share. The company’s quarterly revenue was up 87.9% compared to the same quarter last year.
Masimo Price Performance
MASI stock opened at $121.58 on Thursday. Masimo has a one year low of $108.89 and a one year high of $305.21. The company’s fifty day moving average price is $138.99 and its 200-day moving average price is $138.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.28 and a current ratio of 2.10. The company has a market capitalization of $6.39 billion, a PE ratio of 40.26 and a beta of 0.87.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Masimo by 1.5% during the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after acquiring an additional 71,918 shares during the last quarter. FMR LLC increased its position in Masimo by 1.7% during the second quarter. FMR LLC now owns 2,104,939 shares of the medical equipment provider’s stock valued at $275,052,000 after acquiring an additional 35,438 shares during the last quarter. Nomura Holdings Inc. bought a new position in Masimo during the second quarter valued at $242,537,000. State Street Corp increased its position in Masimo by 1.6% during the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider’s stock valued at $251,928,000 after acquiring an additional 27,261 shares during the last quarter. Finally, Liontrust Investment Partners LLP grew its holdings in shares of Masimo by 19.0% in the second quarter. Liontrust Investment Partners LLP now owns 1,199,300 shares of the medical equipment provider’s stock worth $156,713,000 after purchasing an additional 191,700 shares during the last quarter. Institutional investors own 93.31% of the company’s stock.
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
- Get a free copy of the StockNews.com research report on Masimo (MASI)
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Coupang Stock And Why You Should Care
- This Is No Time To Buy D.R. Horton Stock
- Tightly Held Wendy’s Is Undervalued
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.